Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the recipient of a large growth in short interest in August. As of August 14th, there was short interest totaling 1,295 shares, a growth of 257.7% from the July 30th total of 362 shares. Based on an average trading volume of 1,475 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.1% of the shares of the stock are short sold.
Institutional Investors Weigh In On Gyrodyne
An institutional investor recently bought a new stake in Gyrodyne stock. Susquehanna International Group LLP purchased a new stake in Gyrodyne , LLC (NASDAQ:GYRO – Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 14,186 shares of the real estate investment trust’s stock, valued at approximately $142,000. Susquehanna International Group LLP owned about 0.65% of Gyrodyne as of its most recent SEC filing. Hedge funds and other institutional investors own 71.36% of the company’s stock.
Gyrodyne Price Performance
Shares of GYRO stock opened at $5.28 on Thursday. The firm has a 50-day moving average price of $5.76 and a 200 day moving average price of $7.07. Gyrodyne has a twelve month low of $5.28 and a twelve month high of $11.00.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Stories
- Five stocks we like better than Gyrodyne
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
